Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $392.00 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $180.80 | 2 | $0 (2021) |
| GlaxoSmithKline, LLC. | $109.05 | 2 | $0 (2022) |
| Genentech USA, Inc. | $57.60 | 3 | $0 (2021) |
| Janssen Pharmaceuticals, Inc | $19.09 | 1 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $14.61 | 1 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $10.85 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $19.09 | 1 | Janssen Pharmaceuticals, Inc ($19.09) |
| 2022 | $95.40 | 1 | GlaxoSmithKline, LLC. ($95.40) |
| 2021 | $108.61 | 2 | Novo Nordisk Inc ($89.65) |
| 2020 | $129.79 | 3 | Novo Nordisk Inc ($91.15) |
| 2019 | $10.85 | 1 | AstraZeneca Pharmaceuticals LP ($10.85) |
| 2017 | $28.26 | 2 | Merck Sharp & Dohme Corporation ($14.61) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/12/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.09 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/22/2022 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $95.40 | General |
| Category: RESPIRATORY | ||||||
| 12/27/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: Virology & Specialty Care | ||||||
| 05/18/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $89.65 | General |
| Category: Diabetes | ||||||
| 12/28/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Virology & Specialty Care | ||||||
| 08/20/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $91.15 | General |
| Category: Diabetes | ||||||
| 01/07/2020 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Virology & Specialty Care | ||||||
| 11/13/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $10.85 | General |
| Category: Respiratory | ||||||
| 02/07/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $13.65 | General |
| Category: RESPIRATORY | ||||||
| 01/09/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $14.61 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 264 | 445 | $55,589 | $12,294 |
| 2021 | 12 | 602 | 999 | $113,102 | $27,759 |
| 2020 | 17 | 788 | 970 | $117,018 | $27,886 |
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 144 | 151 | $39,411 | $9,011 | 22.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 40 | 40 | $12,840 | $2,844 | 22.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 28 | 34 | $2,482 | $297.58 | 12.0% |
| 94640 | Inhalation treatment for airway obstruction or sputum production | Office | 2022 | 11 | 11 | $583.00 | $85.90 | 14.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 15 | 15 | $120.00 | $33.54 | 27.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2022 | 11 | 44 | $88.00 | $11.08 | 12.6% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 15 | 150 | $65.00 | $10.09 | 15.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 223 | 237 | $61,265 | $16,001 | 26.1% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 132 | 132 | $41,973 | $9,614 | 22.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 64 | 67 | $4,891 | $644.21 | 13.2% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 11 | 12 | $1,488 | $497.53 | 33.4% |
| 90714 | Vaccine for tetanus and diphtheria toxoids injection into muscle, patient 7 years or older | Office | 2021 | 15 | 15 | $945.00 | $293.21 | 31.0% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 19 | 19 | $665.00 | $242.76 | 36.5% |
| 87880 | Strep test by immunoassay for streptococcus | Office | 2021 | 11 | 11 | $495.00 | $181.83 | 36.7% |
| 81003 | Automated urinalysis test | Office | 2021 | 49 | 51 | $408.00 | $114.75 | 28.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2021 | 13 | 13 | $377.00 | $101.01 | 26.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 33 | 330 | $82.50 | $33.90 | 41.1% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2021 | 20 | 80 | $160.00 | $25.89 | 16.2% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2021 | 12 | 32 | $352.00 | $8.33 | 2.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 229 | 240 | $49,792 | $11,133 | 22.4% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 80 | 80 | $24,640 | $6,457 | 26.2% |
| 87426 | Coronavirus ag ia | Office | 2020 | 101 | 102 | $12,648 | $4,568 | 36.1% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 58 | 58 | $12,354 | $1,982 | 16.0% |
| 87804 | Detection test for influenza virus | Office | 2020 | 35 | 70 | $3,150 | $1,137 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 16 | 16 | $4,896 | $835.15 | 17.1% |
About Dr. Samuel Eng, MD
Dr. Samuel Eng, MD is a Family Medicine healthcare provider based in Olney, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1134199557.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Eng, MD has received a total of $392.00 in payments from pharmaceutical and medical device companies, with $19.09 received in 2023. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($392.00).
As a Medicare-enrolled provider, Eng has provided services to 1,654 Medicare beneficiaries, totaling 2,414 services with total Medicare billing of $67,939. Data is available for 3 years (2020–2022), covering 36 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Olney, MD
- Active Since 01/26/2006
- Last Updated 10/12/2009
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1134199557
Products in Payments
- RYBELSUS (Drug) $180.80
- TRELEGY ELLIPTA (Drug) $95.40
- Xofluza (Drug) $57.60
- XARELTO (Drug) $19.09
- ANORO (Drug) $13.65
- SYMBICORT (Drug) $10.85
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Olney
Brian Atwood, M.d, M.D
Family Medicine — Payments: $13,125
John Horner, M.d, M.D
Family Medicine — Payments: $2,228
Dr. Tik Ka Ng, M.d, M.D
Family Medicine — Payments: $1,896
Mark Mankins, M.d, M.D
Family Medicine — Payments: $966.88
Dr. Johny Edappully, M.d, M.D
Family Medicine — Payments: $498.27
Dr. Alexander Waldherr, Do, DO
Family Medicine — Payments: $404.24